Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,What's New IFI ISICEM 2015

    Anti-infectives Knowledge Network (AIKN) IFI Updates

    Selected slides from the Astellas-sponsored satellite symposium at the 35th International
    Symposium on Intensive Care and Emergency Medicine (ISICEM), held on 17–20 March 2015,
    have been added to the Anti-infectives Knowledge Network – Invasive Fungal Infections.
    View and download for free by visiting the congresses section.

    April 2015 MYC/15/0031/EUb

  • ,

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    Recently updated with ISICEM 2015 presentations, data from the largest ever European
    clinician consensus report, as well as key perspectives on Clostridium difficile infection
    (CDI).
    The Anti-Infectives Knowledge Network shares expertise and experience in the area of
    anti-infectives.

    This educational resource is an initiative by Astellas Pharma EMEA. Please remember
    to return often to read the news, clinical insights, and essential information from the
    latest anti-infectives congresses.

    March 2015 FDX/15/0024/EUb

  • ,

    New Therapy Focus area for
    type 2 diabetes launched

    This free resource has recently launched on epgonline.org containing information
    for healthcare professionals based in Europe on the use of incretin‐insulin treatment
    combinations for type 2 diabetes. Explore five informative sections focused on the role
    emerging incretin‐based therapies can play in the long‐term treatment and management of
    type 2 diabetes.

  • ,Whats's New Diabetes Knowledge Centre Relaunch

    Updated Type 2 Diabetes Mellitus Knowledge Centre

    Explore new information added to the diagnosis and treatment sections of the
    Type 2 Diabetes Mellitus Knowledge Centre with recommendations on the appropriate
    management of the condition. A brand new guidelines section is also available,
    containing the latest recommendations from ADA, EASD and NICE.

  • ,What's New Hypogonadism

    Hypogonadism Knowledge Centre

    epgonline.org’s Hypogonadism Knowledge Centre features a publications digest section,
    regularly updated with analysis and comment on recent scientific articles related to male
    hypogonadism.

    Found within the Men’s Health/Andrology disease topic homepage, users can also access
    information on the prevalence, diagnosis and available treatment options for male
    hypogonadism.

Latest News

Updates to the Anti-infectives Knowledge Network-IFI

28-Apr-2015

The Anti-infectives Knowledge Network – Invasive Fungal Infections (AIKN-IFI) has recently been updated with selected slides from the Astellas-sponsored satellite symposium at the 35th International Symposium on Intensive Care and Emergency ...

Phase III data on Zinforo (ceftaroline fosamil) in CAP and cSSTI-AstraZeneca

28-Apr-2015

AstraZeneca has presented positive Phase III data for Zinforo (ceftaroline fosamil), an antibiotic approved for the treatment of adult patients with complicated skin and soft tissue infections (cSSTI) or community-acquired pneumonia (CAP). The Phase ...

Preliminary Phase III data for Viekirax + Exviera in Hepatitis C- AbbVie

27-Apr-2015

AbbVie has announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase IIIb RUBY-I study evaluating Viekirax (ombitasvir/paritaprevir/ritonavir tablets) + Exviera (dasabuvir tablets) with or without ribavirin (RBV) ...

Phase III ALLY-1 trial of Sovaldi + Daklinza meets endpoint in Hepatitis C-BMS/Gilead

27-Apr-2015

BMS and Gilead have announced that primary endpoints were successfully met in ALLY-1, a Phase III clinical trial evaluating a 12-week regimen of Sovaldi + Daklinza (daclatasvir and sofosbuvir) once-daily with ribavirin for the treatment of patients ...

Success for Dalvance (dalbavancin) in DUR 001-303 Study for ABSSSI- Actavis

26-Apr-2015

DUR 001-303 Study Meets Primary & Secondary Endpoints--- Actavis plc has announced positive top-line results for study DUR001-303, a phase III study comparing a single 1500 mg dose of Dalvance with the same total dose given as two-doses one week ...

CHMP recommends Lixiana (edoxaban) for non-valvular AF, and deep vein thrombosis and pulmonary embolism-Daiichi Sankyo

26-Apr-2015

The EU's CHMP has recommended approval of Lixiana (edoxaban), from Daiichi Sankyo, for the prevention of stroke and systemic embolism (SE) in adult patients with non-valvular atrial fibrillation (NVAF) with one or more risk factors. The CHMP also ...

Positive data from STAR study of NanoKnife system in Pancreatic Cancer-AngioDynamics

26-Apr-2015

Results from the Soft Tissue Ablation Registry (STAR), demonstrate that irreversible electroporation (IRE) with the NanoKnife System, from AngioDynamics, in combination with standard chemotherapy, doubled the overall survival rate of locally advanced ...

Recent Updates

Drugs

Clinical Guidelines

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

test

EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Medical Journals

Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells.

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer

Liraglutide and obesity: a review of the data so far.

MAP Kinase Phosphatase 2 Regulates Macrophage-Adipocyte Interaction.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors